Literature DB >> 8068732

Platelet secretory phospholipase A2 fails to induce rabbit platelet activation and to release arachidonic acid in contrast with venom phospholipases A2.

C Mounier1, B B Vargaftig, P A Franken, H M Verheij, C Bon, L Touqui.   

Abstract

The ability of platelet secretory phospholipase A2 (sPLA2) to induce platelet activation was investigated. sPLA2 (group II) contained in an activated platelet supernatant, as well as high concentrations of purified recombinant platelet sPLA2, failed to induce platelet activation. Furthermore, sPLA2 did not modify platelet activation induced by various agonists. The possible relationship between the failure of this enzyme to induce platelet activation and its origin (mammalian) or its structural group (group II) was then investigated, using pancreatic PLA2s (group I) and venom PLA2s from groups I, II and III. All venom PLA2s induced platelet activation that was accompanied by the liberation of arachidonic acid and was abolished by aspirin. In contrast, as observed for platelet sPLA2, enzymes from hog or bovine pancreas were unable to induce platelet activation even when used at high concentrations. Interestingly, PLA2 able to induce platelet activation efficiently hydrolyse phosphatidylcholine, while those inactive on platelets did not. Taken together, these results suggest that the catalytic activity of added PLA2 is necessary but not sufficient to induce platelet activation. Moreover, the ability of PLA2 to induce platelet activation is not related to its structural group (I, II, III) but rather to its origin (venom vs. mammalian) and capacity to hydrolyse phosphatidylcholine, the major phospholipid of the outer leaflet of the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8068732     DOI: 10.1016/0005-2760(94)90013-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Human group II 14 kDa phospholipase A2 activates human platelets.

Authors:  J Polgár; R M Kramer; S L Um; J A Jakubowski; K J Clemetson
Journal:  Biochem J       Date:  1997-10-01       Impact factor: 3.857

2.  In vivo effect of pancreatic phospholipase A2 on the arachidonic acid cascade.

Authors:  M Motoyoshi; M Sugiyama; Y Atomi; W Kimura; H Nagawa
Journal:  Int J Pancreatol       Date:  2001

3.  Effect of a selective thromboxane A2 synthetase inhibitor on the systemic changes induced by circulating pancreatic phospholipase A2.

Authors:  Makoto Motoyoshi; Masanori Sugiyama; Yutaka Atomi; Wataru Kimura; Hirokazu Nagawa
Journal:  J Gastroenterol       Date:  2006-12-08       Impact factor: 7.527

4.  Platelet phospholipase A2 activity in patients with Alzheimer's disease, vascular dementia and ischemic stroke.

Authors:  E Krzystanek; M Krzystanek; G Opala; H I Trzeciak; J Siuda; A Małecki
Journal:  J Neural Transm (Vienna)       Date:  2007-04-20       Impact factor: 3.575

5.  pH and calcium dependence of hemolysis due to Rickettsia prowazekii: comparison with phospholipase activity.

Authors:  D M Ojcius; M Thibon; C Mounier; A Dautry-Varsat
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.